Local women and children gather at an outdoor market in Africa, showcasing vibrant clothing and community life.
Malawi’s remarkable progress in its fight against tuberculosis, which saw a 40% reduction in cases over a decade, is now under severe threat. The nation is facing a critical shortage of first-line TB drugs, with stocks projected to run out completely by the end of September. This crisis stems from a disruption in global pharmaceutical supplies and significant cuts in international aid from key donors like the US and UK. Health facilities are already scrambling, borrowing dwindling stocks across districts and even rationing patient doses. This dire situation risks undoing years of public health gains, potentially leaving newly diagnosed patients without treatment and causing widespread treatment interruptions. The looming shortage highlights the fragility of health systems reliant on external funding and raises urgent calls for more sustainable, local solutions to safeguard hard-won progress against disease.
The Guardian